Literature DB >> 10397278

A novel polymorphism (-357 G/A) of the ALDH2 gene: linkage disequilibrium and an association with alcoholism.

S Harada1, T Okubo, T Nakamura, C Fujii, F Nomura, S Higuchi, M Tsutsumi.   

Abstract

BACKGROUND: Human mitochondrial aldehyde dehydrogenase (ALDH2) is a major enzyme responsible for the oxidation of acetaldehyde derived from ethanol metabolism. The human ALDH2 gene shows genetic polymorphism at position 1510 with a G to A transition in exon 12. This mutation leads to ALDH2 enzyme deficiency and protection against alcoholism. As yet, no polymorphism for the promoter region of the ALDH2 gene has been reported.
METHODS: We analyzed 600 nucleotides of the promoter region in addition to exon 12 from 571 Japanese, 68 Chinese, 80 Myanmar, 60 Mongolians, and 82 North-American Caucasians using single-strand conformational change polymorphism (SSCP) analysis and the polymerase chain reaction (PCR). PCR products that showed an aberrant banding pattern detected by the SSCP analysis were subjected to PCR direct sequencing.
RESULTS: A novel polymorphism at -357 with a G to A substitution was found in all the population groups, including North-American Caucasians. In addition, the polymorphic status in the promoter and exon 12 suggested linkage disequilibrium between the two loci, which indicated that among Japanese, the ALDH2*2 allele is linked to the G promoter allele, and theALDH2*1 allele is linked to the A allele. A total of 206 healthy male controls and 185 alcoholic male patients with the homozygous ALDH2*1 genotype were analyzed for the polymorphism in the promoter. Genotypic frequencies of GG, GA, and AA for alcoholics were 54.1%, 44.3%, and 1.6%, and those for controls were 52.9%, 40.3%, and 6.8%, respectively. The A allele frequencies for alcoholics and controls were 0.24 and 0.27, respectively. A chi2 test for the entire 3 x 2 table indicated significant variations in the three genotypes (chi2 = 6.40, p < 0.05). However, no significant difference in allelic frequencies between the two groups was observed.
CONCLUSION: This new polymorphism in the ALDH2 promoter is present in all populations studied. Further analysis in other ethnic groups is necessary to establish this as an additional risk factor for alcoholism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10397278

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  9 in total

1.  Discovery of a novel class of covalent inhibitor for aldehyde dehydrogenases.

Authors:  May Khanna; Che-Hong Chen; Ann Kimble-Hill; Bibek Parajuli; Samantha Perez-Miller; Sulochanadevi Baskaran; Jeewon Kim; Karl Dria; Vasilis Vasiliou; Daria Mochly-Rosen; Thomas D Hurley
Journal:  J Biol Chem       Date:  2011-10-21       Impact factor: 5.157

2.  Associations between aldehyde dehydrogenase 2 (ALDH2) genetic polymorphisms, drinking status, and hypertension risk in Japanese adult male workers: a case-control study.

Authors:  Mitsunori Ota; Aya Hisada; Xi Lu; Chihiro Nakashita; Shouta Masuda; Takahiko Katoh
Journal:  Environ Health Prev Med       Date:  2015-08-30       Impact factor: 3.674

3.  Strong protective effect of the aldehyde dehydrogenase gene (ALDH2) 504lys (*2) allele against alcoholism and alcohol-induced medical diseases in Asians.

Authors:  Dawei Li; Hongyu Zhao; Joel Gelernter
Journal:  Hum Genet       Date:  2011-11-20       Impact factor: 4.132

4.  Development of selective inhibitors for human aldehyde dehydrogenase 3A1 (ALDH3A1) for the enhancement of cyclophosphamide cytotoxicity.

Authors:  Bibek Parajuli; Taxiarchis M Georgiadis; Melissa L Fishel; Thomas D Hurley
Journal:  Chembiochem       Date:  2014-03-21       Impact factor: 3.164

Review 5.  Alcohol Dehydrogenases, Aldehyde Dehydrogenases, and Alcohol Use Disorders: A Critical Review.

Authors:  Howard J Edenberg; Jeanette N McClintick
Journal:  Alcohol Clin Exp Res       Date:  2018-11-11       Impact factor: 3.455

6.  The association of alcohol and alcohol metabolizing gene variants with diabetes and coronary heart disease risk factors in a white population.

Authors:  Lise Lotte N Husemoen; Torben Jørgensen; Knut Borch-Johnsen; Torben Hansen; Oluf Pedersen; Allan Linneberg
Journal:  PLoS One       Date:  2010-08-05       Impact factor: 3.240

7.  Selective ALDH3A1 inhibition by benzimidazole analogues increase mafosfamide sensitivity in cancer cells.

Authors:  Bibek Parajuli; Melissa L Fishel; Thomas D Hurley
Journal:  J Med Chem       Date:  2014-01-10       Impact factor: 7.446

8.  Novel and prevalent non-East Asian ALDH2 variants; Implications for global susceptibility to aldehydes' toxicity.

Authors:  Che-Hong Chen; Julio C B Ferreira; Amit U Joshi; Matthew C Stevens; Sin-Jin Li; Jade H-M Hsu; Rory Maclean; Nikolas D Ferreira; Pilar R Cervantes; Diana D Martinez; Fernando L Barrientos; Gibran H R Quintanares; Daria Mochly-Rosen
Journal:  EBioMedicine       Date:  2020-05-08       Impact factor: 8.143

Review 9.  The genetics of alcohol metabolism: role of alcohol dehydrogenase and aldehyde dehydrogenase variants.

Authors:  Howard J Edenberg
Journal:  Alcohol Res Health       Date:  2007
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.